Afrasiabi E et al. |
Sphingosylphosphorylcholine enhances calcium entry in thyroid FRO cells by a mechanism dependent on protein kinase C. |
2006 |
Cell. Signal. |
pmid:16490345
|
Fujiwaki T et al. |
Quantitative evaluation of sphingolipids using delayed extraction matrix-assisted laser desorption ionization time-of-flight mass spectrometry with sphingosylphosphorylcholine as an internal standard. Practical application to cardiac valves from a patient with Fabry disease. |
2006 |
J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. |
pmid:16431168
|
Mathieson FA and Nixon GF |
Sphingolipids differentially regulate mitogen-activated protein kinases and intracellular Ca2+ in vascular smooth muscle: effects on CREB activation. |
2006 |
Br. J. Pharmacol. |
pmid:16402047
|
Alewijnse AE and Michel MC |
Sphingosine-1-phosphate and sphingosylphosphorylcholine: two of a kind? |
2006 |
Br. J. Pharmacol. |
pmid:16402045
|
Jeon ES et al. |
Sphingosylphosphorylcholine induces proliferation of human adipose tissue-derived mesenchymal stem cells via activation of JNK. |
2006 |
J. Lipid Res. |
pmid:16339111
|
Im DS |
Two ligands for a GPCR, proton vs lysolipid. |
2005 |
Acta Pharmacol. Sin. |
pmid:16297340
|
Mogi C et al. |
Sphingosylphosphorylcholine antagonizes proton-sensing ovarian cancer G-protein-coupled receptor 1 (OGR1)-mediated inositol phosphate production and cAMP accumulation. |
2005 |
J. Pharmacol. Sci. |
pmid:16210776
|
van Diggelen OP et al. |
A new fluorimetric enzyme assay for the diagnosis of Niemann-Pick A/B, with specificity of natural sphingomyelinase substrate. |
2005 |
J. Inherit. Metab. Dis. |
pmid:16151905
|
Schubert R |
Non-capacitative calcium entry--extension of the possibilities for calcium entry in vascular tissue. |
2005 |
Cardiovasc. Res. |
pmid:16111665
|
Jin Y et al. |
Human resting CD16-, CD16+ and IL-2-, IL-12-, IL-15- or IFN-alpha-activated natural killer cells differentially respond to sphingosylphosphorylcholine, lysophosphatidylcholine and platelet-activating factor. |
2005 |
Eur. J. Immunol. |
pmid:16078278
|
Thomas GD et al. |
Sphingosylphosphorylcholine-induced vasoconstriction of pulmonary artery: activation of non-store-operated Ca2+ entry. |
2005 |
Cardiovasc. Res. |
pmid:15950201
|
Zhu MJ et al. |
Induction of connective tissue growth factor expression by sphingosylphosphorylcholine in cultured human skin fibroblasts. |
2005 |
Exp. Dermatol. |
pmid:15946238
|
Lu X and Bittman R |
Synthesis of a photoactivatable (2S,3R)-sphingosylphosphorylcholine analogue. |
2005 |
J. Org. Chem. |
pmid:15932314
|
Jeon ES et al. |
Role of MEK-ERK pathway in sphingosylphosphorylcholine-induced cell death in human adipose tissue-derived mesenchymal stem cells. |
2005 |
Biochim. Biophys. Acta |
pmid:15866480
|
Kim KS et al. |
GPR4 plays a critical role in endothelial cell function and mediates the effects of sphingosylphosphorylcholine. |
2005 |
FASEB J. |
pmid:15857892
|
Piao YJ et al. |
Involvement of urokinase-type plasminogen activator in sphingosylphosphorylcholine-induced angiogenesis. |
2005 |
Exp. Dermatol. |
pmid:15854129
|
Sakagami H et al. |
Biochemical and molecular characterization of a novel choline-specific glycerophosphodiester phosphodiesterase belonging to the nucleotide pyrophosphatase/phosphodiesterase family. |
2005 |
J. Biol. Chem. |
pmid:15788404
|
Kamanna VS et al. |
Bioactive lysophospholipids and mesangial cell intracellular signaling pathways: role in the pathobiology of kidney disease. |
2005 |
Histol. Histopathol. |
pmid:15736064
|
Jeon ES et al. |
Sphingosylphosphorylcholine generates reactive oxygen species through calcium-, protein kinase Cdelta- and phospholipase D-dependent pathways. |
2005 |
Cell. Signal. |
pmid:15722202
|
Hedemann J et al. |
Comparison of noradrenaline and lysosphingolipid-induced vasoconstriction in mouse and rat small mesenteric arteries. |
2004 |
Auton Autacoid Pharmacol |
pmid:15541015
|